Market Highlights
- RefinedScience has chosen Fitzsimons Innovation Community in Aurora as its Colorado headquarters, moving from its incubator space to permanent facilities in Bioscience 3.
- Boulder-based Ambrosia Biosciences raised $25.0 million in Series A funding, with $6.0 million from Merck. The startup develops oral therapies for obesity and metabolic disorders.
- Venture capital funding in Denver-Boulder's life sciences sector rose 28.4% from 2023 to 2024, marking one of its strongest years yet.